echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > ACTN: Not to be underestimated!

    ACTN: Not to be underestimated!

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Head injury ( HI ) is considered an important risk factor for dementia and Alzheimer's disease ( AD ).


    Head injury ( HI ) is considered an important risk factor for dementia and Alzheimer's disease ( AD ).


    Recently, a study published inAnnals of Clinical and Translational Neurology evaluated the association between HI and loss of consciousness ( LOC ), aging and brain pathology markers in later life, and explored whether these effects can help explain the absence of dementia Subtle cognitive impairment of the individual.


    Recently, a study published inAnnals of Clinical and Translational Neurology evaluated the association between HI and loss of consciousness ( LOC ), aging and brain pathology markers in later life, and explored whether these effects can help explain the absence of dementia Subtle cognitive impairment of the individual.


    In this study, the researchers investigated from the British MRC National Health and Development Cohort Study in 1946 , involving 502 participants aged69 to 71 years.


    In this study, the researchers investigated from the British MRC National Health and Development Cohort Study in 1946 , involving 502 participants aged69 to 71 years.


    The results of the study showed that the 70 -year-old participants who had experienced severe head injuries 15 years ago performed slightly lower than expected on attention and cognitive tests (a difference of two points, with a score of 46 and 48 on a 93- point scale.


    Average difference in continuous neuroimaging results between 69-71 years old

    However, it is worth noting that the results of the study did not find differences in the levels of amyloid related to Alzheimer's disease, nor did they find other signs of damage related to Alzheimer's disease.


    However, it is worth noting that the results of the study did not find differences in the levels of amyloid related to Alzheimer's disease, nor did they find other signs of damage related to Alzheimer's disease.


    In summary, the study found that even in the general population, experiencing early in life even in the general population, experiencing early in life even in the general population, experiencing HI early in life HI may affect decades later until later in life Cognitive and brain health.


    Original source

    Sarah‐Naomi James et al, A population‐based study of head injury, cognitive function and pathological markers, Annals of Clinical and Translational Neurology (2021).


    James et Al-Naomi sarah, A Population-based Study of head injury, Cognitive function and pathological markers, Annals of Clinical and the Translational.
    Neurology (2021).
      The DOI: 10.
    1002 / acn3.
    51331 the DOI: 10.
    1002 / acn3.
    51331 in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.